Cell cycle phase-specific survival of CD95 ligand-challenged Jurkat cells: Upregulation of heat-shock response

Cellular Immunology

Volumn 211, Issue 1, 2001, Pages 21-29

  Parr, Tyler B ^a   Hofman, Florence M ^a   Kiener, Peter A ^b   Stohl, William ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; CD95 ligand; Heat shock; T lymphocytes

Indexed keywords

FAS ANTIGEN; LIGAND;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA CELL LINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035838264     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.2001.1820     Document Type: Article

References (39)

1. Regulatory T cells in autoimmunity
2. Induction of autoreactive B cells allows priming of autoreactive T cells
3. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
4. Enhanced and accelerated lymphoproliferation in Fas-null mice
5. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
6. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
7. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
8. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
9. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity
10. Missense mutations in the fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis
11. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder
12. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease
13. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice
14. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood
15. + B cell line
16. Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death
17. Identification of amino acid residues important for ligand binding to Fas
18. Improved technique utilizing nonfat dry mild for analysis of proteins and nucleic acids transferred to nitrocellulose
19. Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70
20. Induction of myocardial heat shock protein 70 during cardiac surgery
21. Brucella species release a specific, protease-sensitive, inhibitor of TNF-α expression, active on human macrophage-like cells
22. Expression of human HSP70 during the synthetic phase of the cell cycle
23. Casper is a FADD- and caspase-related inducer of apoptosis
24. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis
25. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis
26. Inhibition of death receptor signals by cellular FLIP
27. CASH, a novel caspase homologue with death effector domains
28. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle
29. T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle
30. Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo-1/CD95-mediated apoptotic cell death in Jurkat T cells
31. Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70
32. Heat-shock protein synthesis by human peripheral mononuclear cells from SLE patients
33. Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus
34. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
35. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
36. Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes
37. FAP-1: A protein tyrosine phosphatase that associates with Fas
38. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells
39. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells